MANISHA KORB: Open Payments
NPI 1235494089 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$57,358 in 126 payments from 21 companies in 2025. Trend: 2023 $52,707 · 2024 $44,519 · 2025 $57,358
Speaker / faculty: $48,716Consulting: $3,711Food & beverage: $2,768Travel & lodging: $2,064Education: $99
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 27 | $20,277 |
| Genentech USA, Inc. | 12 | $17,953 |
| ARGENX US, INC. | 13 | $11,984 |
| Alexion Pharmaceuticals, Inc. | 12 | $3,990 |
| F. Hoffmann-La Roche AG | 5 | $1,605 |
| Janssen Biotech, Inc. | 17 | $545 |
| Eisai Inc. | 5 | $188 |
| UCB, Inc. | 9 | $184 |
| ABBVIE INC. | 8 | $169 |
| Teva Pharmaceuticals USA, Inc. | 1 | $106 |
Products named: SPINRAZA, Evrysdi, VYVGART, ULTOMIRIS, LEQEMBI, QULIPTA, Rystiggo, VYVGART HYTRULO.
Industry payments across FL — which companies pay providers there.
